고감도 옥심에스터 광중합 개시제 및 이를 포함하는 광중합 조성물
    1.
    发明申请
    고감도 옥심에스터 광중합 개시제 및 이를 포함하는 광중합 조성물 审中-公开
    高灵敏度肟酯光聚合引发剂和含有其的光聚合组合物

    公开(公告)号:WO2018008959A1

    公开(公告)日:2018-01-11

    申请号:PCT/KR2017/007132

    申请日:2017-07-05

    Abstract: 본 발명은 광가교 반응에서 광 개시제로 유용한 옥심에스터 페닐카바졸 화합물을 제공한다. 구체적으로는 상기 옥심에스터 구조의 질소원자와 이중 결합하는 탄소원자가 결합되며, (C 1 -C 20 ) 알킬기 또는 (C 6 -C 20 ) 알릴기와도 직접 결합되어 있는 구조를 갖는 것을 특징으로 한다. 본 발명에 따른 화합물 및 이를 포함하는 광중합 조성물은 용해성이 향상되며 광감도가 우수하고, 잔막율, 패턴 안정성 및 레지스트의 밀착력이 우수하므로, LCD의 블랙레지스트, 칼라레지스트, 오버코트, 칼럼스페이서, 유기절연막 등에 유용하다.

    Abstract translation: 本发明提供可用作光交联反应中的光引发剂的肟酯苯基咔唑化合物。 具体而言,自耦合到所述双键的碳原子和肟酯结构的氮原子上,(C <子> 1 -C <子> 20 )烷基或(C <子> 6 20 )。 包含所述化合物,并根据本发明的相同的光聚合的组合物改进了溶解性和光灵敏度优异,并且残留的涂膜,由于图案的密合性是稳定的和抗蚀剂优异,液晶黑色抗蚀剂,彩色抗蚀剂,和外涂层,所述柱状间隔物,有机绝缘膜 这很有用。

    4'-오-데메틸-에피포도필로톡신-베타-디-글루코시드의새로운아세탈유도체,이의제조방법및이를포함하는항암제조성물

    公开(公告)号:KR100321844B1

    公开(公告)日:2004-05-24

    申请号:KR1019980057837

    申请日:1998-12-23

    Abstract: PURPOSE: Acetal derivatives of 4'-O-demethyl-epipodophyllotoxin-a-D-glucoside, a preparation method thereof and an anticancer composition containing the same derivatives are provided, which compounds inhibit activity of human DNA topoisomerase II, and have improved or similar inhibiting activity on the growth of a cancer cell to a prior anticancer compound etoposide, so that it can be useful for prevention and treatment of cancer. CONSTITUTION: The acetal derivatives of 4'-O-demethyl-epipodophyllotoxin-a-D-glucoside represented by formula (1) are provided, wherein R1 and R2 are independently hydrogen, or C2-C12 alkenyl optionally substituted with one or more radicals selected from alkoxy, phenyl, substituted phenyl, halogen, nitro, cyano, hydroxy, carboxyl and amino, C2-C12 alkynyl, C2-C12 alkoxyalkyl or cyclopropyl, or form C5-C15 ring optionally substituted with one or more radicals selected from alkoxy, phenyl, substituted phenyl, halogen, nitro, cyano, hydroxy, carboxyl and amino, provided that R1 and R2 are not hydrogen simultaneously. The method for preparing the acetal derivatives of 4'-O-demethyl-epipodophyllotoxin-a-D-glucoside of formula (I) comprises reacting 4'-O-demethyl-epipodophyllotoxin-a-D-glucoside of formula (II) with aldehyde compound of formula (III) or acetal compounds of formula (IV) under acid catalyst, wherein R3 is C1-3 alkyl.

    테트라히드로피리딘 유도체의 제조방법
    4.
    发明授权
    테트라히드로피리딘 유도체의 제조방법 失效
    四氢吡啶衍生物的制备方法

    公开(公告)号:KR1019930003487B1

    公开(公告)日:1993-05-01

    申请号:KR1019900011883

    申请日:1990-08-02

    Abstract: A process for preparing tetrahydrophridine derivs. of formula (I) comprises (a) reacting a cpd. of formula (II) with a reducing agent; (b) reacting the obtd. cpd. with haloformate in benzene or toluene; (c) removing the alcohol gp. of the obtd. cpd. by acylation, mesylation or tosylation; and (d) adding an amine cpd. to the obtd. cpd. to remove the protecting gp. In the formulas, Q1 and Q2=H or C1-3 alkylene; X=Cl, Br or I; R1 and R2=H, hydroxyamino, C1-3 alkyl substd. amino, N-hydroxyamino or C1-3 alkyl substd. N-hydroxyamino; R3=H or protecting gp.; R4=H, halogen or C1-3 alkyl; R5=benzyl, dimethylphenyl or trityl; R6 and R7 = H, hydroxy, amino, N-hydroxyamino, N-alkyl-N-hydroxyamino or N,O- dialkylhydroxyamino; R8=H, acetyl, mesyl or tosyl.

    Abstract translation: 制备四氢roph啶衍生物的方法。 式(I)的化合物包括(a)使cpd反应。 式(II)的化合物与还原剂反应; (b)反对。 CPD。 与卤代甲酸酯在苯或甲苯中反应; (c)去除酒精gp。 的obtd。 CPD。 通过酰化,甲磺酰化或甲苯磺酰化; 和(d)加入胺cpd。 到达obtd。 CPD。 去除保护gp。 在式中,Q 1和Q 2 = H或C 1-3亚烷基; X = Cl,Br或I; R1和R2 = H,羟基氨基,C1-3烷基。 氨基,N-羟基氨基或C 1-3烷基。 N-羟氨基; R3 = H或保护gp。 R4 = H,卤素或C1-3烷基; R5 =苄基,二甲基苯基或三苯甲基; R6和R7 = H,羟基,氨基,N-羟基氨基,N-烷基-N-羟基氨基或N,O-二烷基羟基氨基; R8 = H,乙酰基,甲磺酰或甲苯磺酰基。

    항균 작용을 갖는 2,5-디히드로-1H-피롤로[3.4.C]피리딘 유도체와 그의 제조방법
    10.
    发明授权
    항균 작용을 갖는 2,5-디히드로-1H-피롤로[3.4.C]피리딘 유도체와 그의 제조방법 失效
    2,5-DIHYDRO-1H-吡咯烷酮| 3,4,C - 吡啶衍生物及其制备方法

    公开(公告)号:KR1019920008165B1

    公开(公告)日:1992-09-24

    申请号:KR1019900011885

    申请日:1990-08-02

    Abstract: Quinolne derivs. of formula (I) and their pharmaceutically acceptable salts are prepd.by condensing a pyridine deriv. of formula (II) and a quinoline carboxylic acid deriv. of formula (III) in the presence (or absence) of a solvent, at room temp. - 200 deg.C for 2-16 hrs. In the formulas, Z1, Z2 nd Z3 each = H, C1-3 alkyl, halogen, cyano, amino, hydroxy, C1-3 alkylamine or alkoxy; R1= ethyl or cyclopropyl; R2 and R3=H,F,Br or Cl; X=N, methyne or fluoromethyne, The cpds. (I) are useful as an antibacterial agent.

    Abstract translation: 喹啉衍生物 式(I)化合物及其药学上可接受的盐是通过将吡啶衍生物缩合制备的。 的式(II)和喹啉羧酸衍生物。 在存在(或不存在)溶剂的情况下,在室温下进行。 - 200℃2-16小时。 在式中,Z 1,Z 2,Z 3各自为H,C 1-3烷基,卤素,氰基,氨基,羟基,C 1-3烷基胺或烷氧基; R1 =乙基或环丙基; R2和R3 = H,F,Br或Cl; X = N,甲炔或氟甲炔,cpds。 (I)可用作抗菌剂。

Patent Agency Ranking